ES2166436T3 - Protector oftalmico biodesgastable. - Google Patents

Protector oftalmico biodesgastable.

Info

Publication number
ES2166436T3
ES2166436T3 ES96907048T ES96907048T ES2166436T3 ES 2166436 T3 ES2166436 T3 ES 2166436T3 ES 96907048 T ES96907048 T ES 96907048T ES 96907048 T ES96907048 T ES 96907048T ES 2166436 T3 ES2166436 T3 ES 2166436T3
Authority
ES
Spain
Prior art keywords
traumatized
bio
gelatin
eye
biodesgastable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96907048T
Other languages
English (en)
Inventor
Alok Nigam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
Original Assignee
Bausch and Lomb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch and Lomb Inc filed Critical Bausch and Lomb Inc
Application granted granted Critical
Publication of ES2166436T3 publication Critical patent/ES2166436T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/12—Bandages or dressings; Absorbent pads specially adapted for the head or neck
    • A61F13/122—Bandages or dressings; Absorbent pads specially adapted for the head or neck specially adapted for the face
    • A61F13/124—Bandages or dressings; Absorbent pads specially adapted for the head or neck specially adapted for the face specially adapted for the eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA INVENCION SE REFIERE A ESCUDOS OFTALMICOS BIOEROSIONABLES QUE CONTIENEN GELATINA, UN GLUCOSAMINOGLUCANO (POR EJEMPLO, SULFATO DE CONDROITINA) Y CARBOXIMETILCELULOSA, ASI COMO A UN METODO PARA TRATAR UN OJO TRAUMATIZADO O "SECO" MEDIANTE LA ADMINISTRACION DE ESCUDOS OFTALMICOS CON BASADO EN GELATINA AL OJO TRAUMATIZADO. LOS ESCUDOS OFTALMICOS SON BIOCOMPATIBLES Y BIOEROSIONABLES EN OJOS TRAUMATIZADOS, NO TRAUMATIZADOS Y SECOS. LOS ESCUDOS OFTALMICOS CON BASADOS EN GELATINA PUEDEN INCLUIR ADICIONALMENTE UNA O MAS SUBSTANCIAS TERAPEUTICAMENTE ACTIVAS QUE SE ADMINISTRAN AL OJO.
ES96907048T 1995-02-14 1996-02-13 Protector oftalmico biodesgastable. Expired - Lifetime ES2166436T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/388,159 US5518732A (en) 1995-02-14 1995-02-14 Bio-erodible ophthalmic shield

Publications (1)

Publication Number Publication Date
ES2166436T3 true ES2166436T3 (es) 2002-04-16

Family

ID=23532942

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96907048T Expired - Lifetime ES2166436T3 (es) 1995-02-14 1996-02-13 Protector oftalmico biodesgastable.

Country Status (9)

Country Link
US (1) US5518732A (es)
EP (1) EP0809486B8 (es)
JP (1) JPH11500032A (es)
AT (1) ATE207735T1 (es)
AU (1) AU694628B2 (es)
CA (1) CA2211376C (es)
DE (1) DE69616514T2 (es)
ES (1) ES2166436T3 (es)
WO (1) WO1996025145A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387407B1 (en) * 1995-09-29 2002-05-14 L.A.M. Pharmaceutical Corporation Topical drug preparations
US6372719B1 (en) * 1998-03-04 2002-04-16 Jay Cunningham ανβ3 integrin antagonists in combination with chemotherapeutic agents
AU2175500A (en) * 1998-12-17 2000-07-03 Alcon Laboratories, Inc. Improved viscoelastic compositions and methods of use
US20030138499A1 (en) * 1998-12-17 2003-07-24 Shah Mandar V. Stable surgical irrigating solutions
JP2002538124A (ja) 1999-03-01 2002-11-12 ヴィスタ サイエンティフィック エルエルシー ムチンを含む眼科用調合物
US20020172712A1 (en) * 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
DE10133870A1 (de) * 2001-07-12 2003-02-06 Chris P Lohmann Ophthalmisches Mittel, Verwendung von EGF zur Behandlung von Dry Eye-Syndrom und Insert zur Verabreichung von EGF am Auge
AU2003243282B2 (en) 2002-05-17 2008-05-01 Othera Holding, Inc. Amelioration of the development of cataracts and other opthalmic diseases
US7825134B2 (en) * 2003-05-19 2010-11-02 Othera Holding, Inc. Amelioration of cataracts, macular degeneration and other ophthalmic diseases
MXPA03011987A (es) * 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
DE102004024635A1 (de) * 2004-05-12 2005-12-08 Deutsche Gelatine-Fabriken Stoess Ag Verfahren zur Herstellung von Formkörpern auf Basis von vernetzter Gelatine
EP2535041A1 (en) * 2005-09-09 2012-12-19 Ottawa Health Research Institute Interpenetrating networks, and related methods and composition
CN103497148B (zh) 2007-02-22 2016-06-01 科尔比制药公司 羟胺化合物及其用法
US20080243095A1 (en) * 2007-03-26 2008-10-02 Theta Research Consultants, Llc Method and Apparatus for Ophthalmic Medication Delivery and Ocular Wound Recovery
US20090131303A1 (en) * 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye
US20090142292A1 (en) * 2007-12-03 2009-06-04 Blackwell Richard I Method For The Mitigation of Symptoms of Dry Eye
HRP20150097T1 (hr) * 2008-05-07 2015-03-27 The Regents Of The University Of California Terapijska nadopuna i poboljšanje vlaženja površine oka
US20090297578A1 (en) * 2008-06-03 2009-12-03 Trollsas Mikael O Biosoluble coating comprising anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders
US20100198348A1 (en) * 2009-01-30 2010-08-05 Hiles Michael C Biomaterials with modified optical character and methods for preparing and using same
US8993626B2 (en) 2010-06-25 2015-03-31 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treatment using sterculic acid
MX364260B (es) 2012-08-10 2019-04-17 Osio Corp D/B/A Yolia Health Uso de lentes de contacto en el tratamiento de una afección oftalmológica.
JP6989757B2 (ja) * 2017-06-19 2022-02-03 澁谷工業株式会社 ゼラチン架橋体の製造方法および製造装置
US11766421B2 (en) 2017-09-25 2023-09-26 Surface Ophthalmics, Inc. Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
JP2022516099A (ja) 2018-12-27 2022-02-24 サーフィス オフサルミクス，インコーポレイテッド 眼科用医薬組成物及び癌表面疾患の処置方法
JP7311983B2 (ja) * 2019-03-01 2023-07-20 大日本印刷株式会社 ゲル膜の製造方法およびゲル膜
US12440510B2 (en) 2021-05-10 2025-10-14 Surface Ophthalmics, Inc. Use of chondroitin sulfate for relieving ocular pain
CN117979951A (zh) 2021-05-10 2024-05-03 瑟菲斯眼科股份有限公司 一种用于缓解眼部疼痛的硫酸软骨素的用途

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3710796A (en) * 1971-05-14 1973-01-16 C Neefe Corneal drug delivery method
US3993071A (en) * 1971-09-09 1976-11-23 Alza Corporation Bioerodible ocular device
US3960150A (en) * 1971-09-09 1976-06-01 Alza Corporation Bioerodible ocular device
US3981303A (en) * 1971-09-09 1976-09-21 Alza Corporation Bioerodible ocular device
US3986510A (en) * 1971-09-09 1976-10-19 Alza Corporation Bioerodible ocular device
US3914402A (en) * 1973-06-14 1975-10-21 Alza Corp Ophthalmic dosage form, for releasing medication over time
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
US4233360A (en) * 1975-10-22 1980-11-11 Collagen Corporation Non-antigenic collagen and articles of manufacture
US4164559A (en) * 1977-09-21 1979-08-14 Cornell Research Foundation, Inc. Collagen drug delivery device
US4223984A (en) * 1979-04-04 1980-09-23 Opticol Corporation Collagen soft contact lens
US4264155A (en) * 1979-07-09 1981-04-28 Opticol Corporation Collagen contact lens
US4505855A (en) * 1982-09-30 1985-03-19 Massachusetts General Hospital Transparent non-fibrilized collagen material by ultracentrifugation
US4581030A (en) * 1982-09-30 1986-04-08 Massachusetts General Hospital Collagen replacement prothesis for the cornea
US4600533A (en) * 1984-12-24 1986-07-15 Collagen Corporation Collagen membranes for medical use
SU1321420A1 (ru) * 1985-06-19 1987-07-07 Московский научно-исследовательский институт микрохирургии глаза Способ изготовлени коллагенового покрыти дл использовани в офтальмологии
US5304169A (en) * 1985-09-27 1994-04-19 Laser Biotech, Inc. Method for collagen shrinkage
US5128134A (en) * 1986-09-17 1992-07-07 Fyodorov Svyatoslav N Ophthalmological collagen coverings
US5263992A (en) * 1986-10-17 1993-11-23 Bio-Metric Systems, Inc. Biocompatible device with covalently bonded biocompatible agent
US5156839A (en) * 1987-05-04 1992-10-20 Mdr Group, Inc. Viscoelastic fluid for use in spine and general surgery and other surgery and therapies and method of using same
US5036056A (en) * 1987-07-08 1991-07-30 Martin Kludas Methods for treating damaged corneal, uterine, or cartilage tissue
US5053388A (en) * 1987-11-09 1991-10-01 Chiron Ophthalmics, Inc. Wound healing composition and method
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
FR2627078B1 (fr) * 1988-02-16 1994-03-18 Allergan Inc Dispositif oculaire
US5137728A (en) * 1988-03-01 1992-08-11 Bausch & Lomb Incorporated Ophthalmic article
US4865846A (en) * 1988-06-03 1989-09-12 Kaufman Herbert E Drug delivery system
US5264214A (en) * 1988-11-21 1993-11-23 Collagen Corporation Composition for bone repair
US5306500A (en) * 1988-11-21 1994-04-26 Collagen Corporation Method of augmenting tissue with collagen-polymer conjugates
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5304595A (en) * 1988-11-21 1994-04-19 Collagen Corporation Collagen-polymer conjugates
US4946450A (en) * 1989-04-18 1990-08-07 Biosource Genetics Corporation Glucan/collagen therapeutic eye shields
US5246013A (en) * 1989-12-22 1993-09-21 Massachusetts Institute Of Technology Probe, system and method for detecting cartilage degeneration
US5185152A (en) * 1990-01-10 1993-02-09 Peyman Gholam A Method and apparatus for controlled release drug delivery to the cornea and anterior chamber of the eye
US5259998A (en) * 1991-10-04 1993-11-09 Chiron Ophthalmics, Inc. Method for casting dissolvable ophthalmic shields in a mold
US5270051A (en) * 1991-10-15 1993-12-14 Harris Donald H Enzyme-orthokeratology
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
JPH08503701A (ja) * 1992-10-28 1996-04-23 サイトアーレクス・コーポレーシヨン 眼科用溶液および使用方法

Also Published As

Publication number Publication date
CA2211376C (en) 2000-10-24
AU5023196A (en) 1996-09-04
EP0809486B8 (en) 2002-09-11
ATE207735T1 (de) 2001-11-15
US5518732A (en) 1996-05-21
DE69616514T2 (de) 2002-07-11
EP0809486A1 (en) 1997-12-03
AU694628B2 (en) 1998-07-23
CA2211376A1 (en) 1996-08-22
DE69616514D1 (de) 2001-12-06
EP0809486B1 (en) 2001-10-31
JPH11500032A (ja) 1999-01-06
WO1996025145A1 (en) 1996-08-22

Similar Documents

Publication Publication Date Title
EP0809486B8 (en) Bio-erodible ophthalmic shield
EE9700286A (et) Miootiliste ja müdriaatiliste ravimite kontrollitav vabanemine silma eeskambris
FI972781A7 (fi) Deskarboetoksiloratadiinin (DCL) tai sen farmaseuttisesti hyväksyttävän suolan käyttö valmistettaessa farmaseuttista tuotetta
ES2152556T3 (es) Composiciones que contienen derivados del acido hidroperoxieicosatetraenoico y procedimientos de utilizacion en el tratamiento de trastornos de la sequedad ocular.
CA2126083A1 (en) Use of app modulators for the manufacture of a medicament for the treatment of amyloidosis
PL291446A1 (en) Agent for treating fibre as well as for hair and skin care
FI970489A7 (fi) Paikallisesti käytettäviä silmälääkekoostumuksia, jotka sisältävät dok sepiinijohdoksia ja soveltuvat allergisten silmäsairauksien hoitoon
PT881901E (pt) Novas associacoes de principios activos contendo clopidogrel e um agente anti-trombotico
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
ATE414517T1 (de) Verabreichung von injizierbarem antibiotikum in das ohr eines tieres
MY117526A (en) N-(3-benzofuranyl)urea-derivatives
DE69034070D1 (de) Racemisches Huperzin A
DK0837935T3 (da) Den 3'-ikke-translaterede region af det humane prohibitin-gen
GR3023021T3 (en) Synergising association having an antagonist effect on nk1 and nk2 receptors.
DE3273950D1 (en) Use of 1-(p-isopropoxyethoxymethyl-phenoxy)-3-isopropylaminopropan-2-ol for the preparation of a medicament for the reduction of internal pressure in the eye
IT1098997B (it) Procedimento per l'applicazione di occhi di supporto su parti di costruzione da supportare in modo oscillabile
BR9506549A (pt) Derivados de benzilamina contendo grupos nitróxi e sua aplicação para o tratamento de enfermidades cardiovasculares bem como de pressão interna dos olhos elevada
SU648187A1 (ru) Состав дл консервировани роговиц человека
ATE181669T1 (de) Verwendung von remacemid zur behandlung des morbus parkinson
IT7829846A0 (it) Composizione farmaceutica per la cura della sordita' e del ronzio auricolare.
RU96109603A (ru) Способ лечения воспалительных заболеваний роговицы
CA2192209A1 (en) Treatment of optic neuritis
HU9300468D0 (en) New phospholipide derivatives of nucleosides, their production and their application as active agent of anti-viral pharmaceutical preparatives
ATE224729T1 (de) Verwendung von hyaluronidase
GB8911536D0 (en) Artificial iris and/or sclera

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 809486

Country of ref document: ES